Figures & data
Table 1. Participant’s characteristics at index date×.
Table 2. Proportion of patients with moderate to severe psoriasis who used at least once systemic treatments or phototherapy, by study year (n = 1,848 patients).
Figure 1. Study population selection process.
Figure 2. Systemic treatments and phototherapy sequences in patients with moderate to severe psoriasis after their index date (n = 1,848 patients).
Figure 3. Systemic treatments and phototherapy sequences in patients treated with biotherapies before and after the index date (n = 351 patients).
Figure 4. Estimated mean healthcare costs in patients with moderate to severe psoriasis (all diseases and injuries) and in control patients, computed with the GEE model.
Supplemental Material
Download MS Word (419.9 KB)Data availability statement
The data supporting the study findings are part of the National health data system (SNDS, Système national des Données de Santé) and are available from the HDH (Health Data Hub https://www.health-data-hub.fr/). Restrictions apply to the availability of these data, which were used with a special permission granted by the HDH (File No. 3358814) on 20 January 2021.